GLP-1 agonists appear to have applications beyond diabetes and weight loss
However, with exogenous GLP-1 RAs, active levels of GLP-1 RAs can rise to 10-30 times the normal physiological levels (depending on the agent used) and maintain steadily high levels independent of meal ingestion
Rushing through preparation or not letting the alcohol swab dry completely can lead to moisture being pushed into the skin with the needle
Prior to surgery is it beneficial to use decompressive therapy including compression garments, manual lymphatic massage and lymph-press or pneumatic devices to reduce inflammatory fluid in the legs
GLP-1s are distinct from previous classes of prescription weight loss drugs such as phentermine, as they target essential metabolic pathways
Clinical trials show semaglutide (Wegovy) produces average weight loss of approximately 15% over 68 weeks, liraglutide (Saxenda) around 810% over one year, and tirzepatide over 20% in some participants, all combined with lifestyle interventions